Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

04 May 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated May 4, 2024 titled ‘Sentynl Therapeutics announces global acquisition of Zokinvy® (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from Eiger Biopharmaceuticals’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..